Handling and reporting of nephrectomy specimens for adult renal tumours: A survey by the European Network of Uropathology

Journal of Clinical Pathology

Volumn 65, Issue 2, 2012, Pages 106-113

  Algaba, Ferran ^a   Delahunt, Brett ^b   Berney, Daniel M ^c   Camparo, Philippe ^d   Compérat, Eva ^e   Griffiths, David ^f   Kristiansen, Glen ^g   Lopez Beltran, Antonio ^h   Martignoni, Guido ⁱ   Moch, Holger ^j   Montironi, Rodolfo ^k   Varma, Murali ^f   Egevad, Lars ^l  

^a FUNDACIÓ PUIGVERT   (Spain)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d FOCH HOSPITAL   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^g UNIVERSITY HOSPITAL BONN   (Germany)

^h Universidad de Cordoba   (Spain)

ⁱ UNIVERSITY OF VERONA   (Italy)

^j UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^k UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^l KAROLINSKA INSTITUTE   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; FORMALDEHYDE; MONOCLONAL ANTIBODY HMB 45; VIMENTIN;

ALGORITHM; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER PATIENT; CLINICAL PRACTICE; CONSENSUS DEVELOPMENT; EUROPE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CANCER; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; KIDNEY TUMOR; LABORATORY DIAGNOSIS; LYMPH NODE; NEPHRECTOMY; PAPILLOMA; PATHOLOGIST; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; STANDARDIZATION; TUMOR CLASSIFICATION; TUMOR VOLUME; WORLD HEALTH ORGANIZATION;

ADULT; ALGORITHMS; EUROPE; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HUMANS; KIDNEY NEOPLASMS; NEOPLASM GRADING; NEPHRECTOMY; PATHOLOGY, CLINICAL; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; SPECIMEN HANDLING;

EID: 84856080129     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2011-200339     Document Type: Article

References (44)

1. Mostofi FK, Sesterhenn IH, Sobin LH, et al. Histological Typing of Kidney Tumours. International Histological Classification of Tumours No. 25. Genova: World Health Organization, 1981;26.
2. Srigley JR, Delahunt B. Uncommon and recently described renal carcinomas. Mod Pathol 2009;22:S2-23.
3. Allory Y, Culine S, de la Taille A. Kidney cancer pathology in the new context of targeted therapy. Pathobiology 2011;78:90S2-238.
4. Delahunt B, Bethwaite PB, Nacey JN. Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype. Pathology 2007;39:4549e65. Suppl 2:S2-S23.
5. Eble JN. Recommendations for examining and reporting tumor-bearing kidney specimens from adults. Semin Diagn Pathol 1998;15:77e82. Suppl 2:S24-36.
6. Algaba F, Trias I, Scarpelli M, et al. Handling and pathology reporting of renal tumor specimens. Eur Urol 2004;45:437-43. (Pubitemid 38376200)
7. Che M, Grignon DJ. Handling and reporting of tumor-containing kidney specimens. Clin Lab Med 2005;25:417-32. (Pubitemid 40545827)
8. Higgins JP, McKenney JK, Brooks JD, et al. Recommendations for the reporting of surgically resected specimens of renal cell carcinoma. The Association of Directors of Anatomic and Surgical Pathology. Hum Pathol 2009;40:456-63.
9. Delahunt B, Charles A, Clouston D, et al. Renal Parenchymal Malignancy (renal cell carcinoma). Structured Reporting Protocol. Sydney: Royal College of Pathologists of Australasia, 2010;51.
10. Srigley JR, Amin MB, Delahunt B, et al. Protocol for the examination of specimens from patients with invasive carcinoma of renal tubular origin. Arch Pathol Lab Med 2010;134:e25-30.
11. Egevad L, Algaba F, Berney DM, et al The European Network of Uropathology. A novel mechanism for communication between pathologists. Anal Quant Cytol Histol 2009;31:90-5.
12. Egevad L, Algaba F, Berney DM, et al. Handling and reporting of radical prostatectomy specimens in Europe: a web-based survey by the European Network of Uropathology (ENUP). Histopathology 2008;53:333-9.
13. Dimashkieh HH, Lohse CM, Blute ML, et al. Extranodal extension in regional lymph nodes is associated with outcome in patients with renal cell carcinoma. J Urol 2006;176:1978e82.
14. Algaba F, Arce Y, López-Beltrán A, et al European Society of Uropathology; Uropathology Working Group. Intraoperative frozen section diagnosis in urological oncology. Eur Urol 2005;47:129-36. (Pubitemid 40126968)
15. Boorjian SA, Crispen PL, Lohse CM, et al. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses. Eur Urol 2008;54:855-63.
16. Brennan C, Srigley JR, Wheelan C, et al. Type 2 and clear cell papillary renal cell carcinoma, and tubulocystic carcinoma. A unifying concept. Anticancer Res 2010;30:641-4.
17. Delahunt B. Advances and controversies in the grading and staging of renal cell carcinoma. Mod Pathol 2009;22:S24-36.
18. Jeffery NN, Douek N, Guo DY, et al. Discrepancy between radiological and pathological size of renal masses. BMC Urol 2011;11:2.
19. Kanofsky J, Phillips C, Stifelman M, et al. Impact of discordant radiologic and pathologic tumour size on renal cancer staging. Urology 2006;68:728-31. (Pubitemid 44633408)
20. Sobin LH, Gospodarowicz M, Wittekind Ch, eds. International Union Against Cancer. TNM Classification of Malignant Tumours, 7th edn. New York, NY: Wiley-Liss, 2009.
21. Bonsib SM. The renal sinus is the principal invasive pathway: a prospective study of 100 renal cell carcinomas. Am J Surg Pathol 2004;28:1594-600. (Pubitemid 39564964)
22. Bonsib SM. T2 clear cell renal cell carcinoma is a rare entity: a study of 120 clear cell renal cell carcinoma. J Urol 2005;174:1199-202. (Pubitemid 41318679)
23. Bonsib SM. Renal lymphatic and lymphatic involvement in sinus vein invasive (pT3b) clear cell renal cell carcinoma. A study of 40 cases. Mod Pathol 2006;19:746-53.
24. Bonsib SM. Renal vein and venous extension in clear cell renal cell carcinoma. Mod Pathol 2007;209:44-53. (Pubitemid 44967949)
25. Eble JN, Sauter G, Epstein JI, et al, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press, 2004.
26. Brunelli M, Delahunt B, Gobbo S, et al. Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma. a validation study combining metaphase and interphase analyses. Am J Clin Pathol 2010;133:116-26.
27. Brunelli M, Fiorentino M, Gobbo S, et al. Many facets of chromosome 3p cytogenetic findings in clear cell renal carcinoma: the need for agreement in assessment FISH analysis to avoid diagnostic errors. Histol Histopathol 2011;26:1207-13.
28. Delahunt B, Eble JN. Papillary adenoma of the kidney an evolving concept. J Urol Pathol 1997;7:99-112. (Pubitemid 128015122)
29. Algaba F. Renal adenomas: pathological differential diagnosis with malignant tumors. Adv Urol 2008;97:4848.
30. Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 1997;10:537-44. (Pubitemid 27293491)
31. Sika-Paotonu D, Bethwaite PB, McCredie MR, et al. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. Am J Surg Pathol 2006;30:1091-6. (Pubitemid 44299341)
32. Delahunt B, Sika-Paotonu D, Bethwaite PB, et al. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma. Am J Surg Pathol 2007;31:957-60. (Pubitemid 47165152)
33. Delahunt B, Sika-Paotonu D, Bethwaite PB, et al. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence. Am J Surg Pathol 2011;35:1134-9.
34. de Peralta-Venturina M, Moch H, Amin M, et al. Sarcomatoid differentiation in renal cell carcinoma. A study of 101 cases. Am J Surg Pathol 2001;25:275-84. (Pubitemid 32174196)
35. Delahunt B, Bethwaite PB, McCredie MR, et al. The evolution of collagen expression in sarcomatoid renal cell carcinoma. Hum Pathol 2007;38:1372-7. (Pubitemid 47247480)
36. Cheville JC, Lohse CM, Zinke BS, et al. Comparison of outcome and prognostic features among histologic subytpes of renal cell carcinoma. Am J Surg Pathol 2003;27:612-24. (Pubitemid 36514472)
37. Kim H, Cho NH, Kim D, et al. Renal cell carcinoma in South Korea: a multicenter study. Hum Pathol 2004;35:1556-63. (Pubitemid 40017998)
38. Moch T, Gasser T, Amin MB, et al. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma. A Swiss experience with 588 tumors. Cancer 2000;89:604-14. (Pubitemid 30640107)
39. Algaba F. Is tumor necrosis a predictor of survival in patients with renal cell carcinoma? Nat Clin Pract Urol 2006;3:196-7.
40. Madbouly K, Al-Qahtani SM, Ghazwani Y, et al. Microvascular tumour invasion: prognostic significance in low stage renal cell carcinoma. Urology 2007;69:670-4. (Pubitemid 46574932)
41. Van Poppel H, Nilsson S, Algaba F, et al. Precancerous lesions in the kidney. Scand J Urol Nephrol Suppl. 2000;205:136-65. (Pubitemid 32056471)
42. Fleming S. Renal cell carcinoma in acquired cystic kidney disease. Histopathology 2010;56:395-400.
43. Henriksen KJ, Meehan SM, Chang A. Non-neoplastic renal diseases are often unrecognized in adult tumor nephrectomy specimens: a review of 246 cases. Am J Surg Pathol 2007;31:1703-8. (Pubitemid 350287568)
44. Henriksen KJ, Meehan SM, Chang A. Nonneoplastic kidney diseases in adult tumor nephrectomy and nephroureterectomy specimens: common, harmful, yet underappreciated. Arch Pathol Lab Med 2009;133:1012-25.